about
Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipaseThe secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse modelPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsMetabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprintTranscriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factorsA-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs.The binding mode of cladocoran A to the human group IIA phospholipase A(2).Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link.Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque.Evolving targets for lipid-modifying therapySecretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells.Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patientsLipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.Effects of human parvovirus B19 VP1 unique region protein on macrophage responses.Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.Acute phase reactants as novel predictors of cardiovascular disease.Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A2, lipoxygenase, and cyclooxygenase.The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.Lipid parameters for measuring risk of cardiovascular disease.Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomicsFrom circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.Biomarkers of plaque instability.The immunology of atherosclerosis.Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease.Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells.Secreted phospholipase A2 enzymes as therapeutic targets.Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification.Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.Purification and biochemical characterization of a secreted group IIA chicken intestinal phospholipase A₂.Macrophages, extracellular matrix, and lipoproteins in arterial cholesterol balance.Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells.Secretory phospholipase A2 induces dendritic cell maturation.Apolipoproteins and diabetic retinopathy.
P2860
Q24315825-B361431B-351B-4928-ADE4-87C9B2EDE5B0Q24317652-35C481D6-C330-4D68-AE7F-CC6182C29D08Q24635932-DC3230AE-6B43-4251-B0C1-4B843D0E9756Q28286551-62E72174-5EFA-48AC-B635-AA4BD6E5C903Q28481255-A50BBE42-FC67-4779-99A8-9C29F1C3494CQ28564877-6FB24167-3364-41FF-8825-1EA688AC79D6Q33410007-D5E4BDAE-7BC5-4A87-84AD-CD06F6DF8A0DQ34033380-1997B559-C8AC-41DC-AF22-9F55A44CC5D4Q34480613-02778F3C-CC7D-4761-8B21-FE89AF4B6D28Q34837405-52B64B18-2087-47FE-8490-81E968E92C1CQ34880292-BD0C7687-B72E-4542-BA6F-EFC94C1FC110Q35094556-7B432424-9A15-4882-8F94-288E1C522CC0Q35917944-A8A5ACC3-D4B9-45CE-B30F-138FE11E7365Q36734411-7F7EF19E-4263-445F-A1CD-8997E604E79FQ36847210-4C6DD234-4367-4343-B748-A3545B0F7840Q36913022-0D38A46B-0848-455B-A6E6-E7F70EDC4DA8Q36975612-7357DF26-67A0-4C2D-B549-4FEB2A09EAD7Q37097742-7320CCEE-FB0D-4532-99ED-5ACFE0C844B4Q37122784-AF1DD9FC-EFA3-43C5-A963-4C0B56CB1CD3Q37142814-F60728B5-A764-48C0-8FB8-51B547959512Q37156874-674ED810-9F46-47CF-8007-07582F641745Q37344692-0F851BC7-4F78-438E-9AAB-B89B341C0147Q37435082-6145FD14-EDB9-4593-ABDA-B6756150EA3EQ37445865-B824F78C-CFFB-48F6-B7CC-0001850AA2E2Q37492990-23F28939-932C-47EE-B3F5-9918FBE9240EQ37833906-47D87025-8C06-4870-A2C8-36FE16608995Q37858911-5E3A0504-ECA9-499D-B6A9-BB9125B6C10FQ37881966-7643A6CA-E2AC-49CA-9843-7C170B6BE740Q38261198-F05933E8-5B62-4171-8D41-FFF87CBA3CD8Q39230390-30E2242F-B7BB-469D-896A-062561348ED6Q39256623-88EE5D7F-92E2-4FC0-AC23-FFBA67FFAC34Q40499280-0260FD23-6111-41A1-9D9E-AA690B6D71D6Q40584187-DFC707BF-4A01-48B8-AC79-CE7DD358CF1EQ40643667-77819A9F-15BC-408F-973F-B78E0F3EE79AQ41530349-778838D2-1F8A-43B7-917E-6A70C0C1CB3FQ41841775-57FF5688-6737-4FCE-9519-047F6CDB765AQ41962079-FCD2E326-B182-4889-9803-9A09DB346905Q42069938-0B972503-B369-44F7-8F89-72A7D5672920Q42575170-74653A56-F379-4141-8E43-72329C0AE3FBQ42576522-9EDCB3F6-1A4E-4599-B062-7DC65A0BD540
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phospholipase A(2) in vascular disease.
@ast
Phospholipase A(2) in vascular disease.
@en
type
label
Phospholipase A(2) in vascular disease.
@ast
Phospholipase A(2) in vascular disease.
@en
prefLabel
Phospholipase A(2) in vascular disease.
@ast
Phospholipase A(2) in vascular disease.
@en
P2093
P356
P1433
P1476
Phospholipase A(2) in vascular disease.
@en
P2093
P304
P356
10.1161/HH1601.095598
P577
2001-08-01T00:00:00Z